352940 — Enbio Co Balance Sheet
0.000.00%
- KR₩31bn
- KR₩47bn
- KR₩34bn
Annual balance sheet for Enbio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,763 | 11,539 | 25,088 | 15,621 | 5,003 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 26,023 | 25,300 | 24,153 | 25,675 | 15,041 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 44,661 | 53,608 | 70,715 | 68,055 | 46,569 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11,060 | 10,768 | 11,136 | 10,317 | 10,971 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 62,132 | 71,477 | 90,605 | 87,360 | 66,319 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 32,624 | 33,394 | 38,242 | 39,047 | 25,067 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 33,862 | 34,523 | 40,689 | 40,871 | 25,592 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 28,270 | 36,954 | 49,915 | 46,488 | 40,726 |
Total Liabilities & Shareholders' Equity | 62,132 | 71,477 | 90,605 | 87,360 | 66,319 |
Total Common Shares Outstanding |